The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
17 June 2019
Employment effect (start)
1 July 2019
Foreseen end date
31 January 2021
Description
South African laboratory Aspen has announced the creation of 100 new jobs by 2021 at its Notre-Dame-de-Bondeville plant thanks to a €65 million investment for the production of injectable anesthetic drugs. The new building will produce 48 million units of these drugs that were previously manufactured by its partner AstraZeneca in Sweden and Australia, Aspen said.
Aspen took over this site in 2014 from the British pharmaceutical company GSK, and had already invested nearly €60 million over the 2014-2018 period to modernise it. The site, which currently employs nearly 700 people, is specialised in the production of sterile injectable drugs, but until now has only manufactured products of the anticoagulant family. The factory exports 92% of its ouput.
Eurofound (2019), Aspen, Business expansion in France, factsheet number 98059, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/98059.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
